Ipsen SA (IPN):企業の財務・戦略的SWOT分析

◆英語タイトル:Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1638
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Ipsen SA (IPN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ipsen SA (Ipsen) is a global specialty biopharmaceutical company that manufactures and distributes drugs for the treatment of cancer and rare and neurological diseases. The company develops and commercializes novel medicines in cancer, neuroscience and rare diseases. It also offers products to treat gastrointestinal disorders, neurodegenerative pathologies and rheumatology diseases. Ipsen sells its drugs through distributors and directly to hospitals in few countries. It has research and development (R&D) facilities in Paris-Saclay, France; Oxford, the UK; and Cambridge, the US. The company offers products in Europe, North America, Asia and rest of the world. Ipsen is headquartered in Paris, France.

Ipsen SA Key Recent Developments

Apr 22,2020 Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact
Apr 01,2020 Ipsen donates two million euros to the Institut Pasteur to support research on COVID-19
Feb 13,2020 Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook
Jan 14,2020 Ipsen appoints Steven Hildemann, MD., PhD as Executive Vice President, Chief Medical Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Ipsen SA – Key Facts
Ipsen SA – Key Employees
Ipsen SA – Key Employee Biographies
Ipsen SA – Major Products and Services
Ipsen SA – History
Ipsen SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Ipsen SA – Business Description
Business Segment: Consumer Healthcare
Overview
Performance
Business Segment: Specialty Care
Overview
Performance
Geographical Segment: Major Western European Countries
Target Markets
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other European Countries
Target Markets
Performance
Geographical Segment: Rest of the World
Target Markets
Performance
R&D Overview
Ipsen SA – Corporate Strategy
Ipsen SA – SWOT Analysis
SWOT Analysis – Overview
Ipsen SA – Strengths
Ipsen SA – Weaknesses
Ipsen SA – Opportunities
Ipsen SA – Threats
Ipsen SA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Ipsen SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Ipsen SA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Ipsen SA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 22, 2020: Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact
Apr 01, 2020: Ipsen donates two million euros to the Institut Pasteur to support research on COVID-19
Feb 13, 2020: Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook
Jan 14, 2020: Ipsen appoints Steven Hildemann, MD., PhD as Executive Vice President, Chief Medical Officer
Dec 18, 2019: Ipsen announces departure of David Meek as chief executive officer
Nov 05, 2019: Ipsen appoints Howard Mayer, M.D. as Executive Vice President and head of Research and Development
Oct 23, 2019: Ipsen delivers strong double-digit sales growth for the third quarter of 2019 and confirms full year 2019 guidance
Oct 16, 2019: Ipsen gains licence to Blueprint Medicines’ FOP drug candidate
Jul 25, 2019: Ipsen delivers strong results for the first half of 2019 with robust double-digit sales growth and improved Core Operating margin and upgrades its guidance for full year 2019
May 14, 2019: Ipsen to host an Investor Day to highlight its innovative R&D pipeline and provide financial outlook for 2022
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Ipsen SA, Key Facts
Ipsen SA, Key Employees
Ipsen SA, Key Employee Biographies
Ipsen SA, Major Products and Services
Ipsen SA, History
Ipsen SA, Subsidiaries
Ipsen SA, Joint Venture
Ipsen SA, Key Competitors
Ipsen SA, Ratios based on current share price
Ipsen SA, Annual Ratios
Ipsen SA, Annual Ratios (Cont...1)
Ipsen SA, Annual Ratios (Cont...2)
Ipsen SA, Interim Ratios
Ipsen SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Ipsen SA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Ipsen SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Ipsen SA, Performance Chart (2015 - 2019)
Ipsen SA, Ratio Charts
Ipsen SA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Ipsen SA, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Ipsen SA (IPN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Komax Holding AG (KOMN):企業の財務・戦略的SWOT分析
    Komax Holding AG (KOMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • GenMark Diagnostics Inc (GNMK):企業の製品パイプライン分析2018
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • PICC Property and Casualty Company Limited:戦略・SWOT・企業財務分析
    PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report Summary PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Stereotaxis Inc (STXS)-製薬・医療分野:企業M&A・提携分析
    Summary Stereotaxis Inc (Stereotaxis) is a healthcare technology company that designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch Solution is an advanced remote robotic navigation system for …
  • United Spirits Ltd:企業の戦略・SWOT・財務情報
    United Spirits Ltd - Strategy, SWOT and Corporate Finance Report Summary United Spirits Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Maple Leaf Foods Inc (MFI):企業の財務・戦略的SWOT分析
    Maple Leaf Foods Inc (MFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • CMS Energy Corporation:発電所・企業SWOT分析
    CMS Energy Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Spire Inc (SR):石油・ガス:M&Aディール及び事業提携情報
    Summary Spire Inc (Spire), formerly Laclede Group, Inc., is a public utility, which carries out the sale, marketing and retail distribution of natural gas. It also markets natural gas and related activities on a non-regulated basis. The company also conducts transportation of liquid propane; real es …
  • Banco Nacional de Obras y Servicios Publicos SNC:企業の戦略・SWOT・財務情報
    Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report Summary Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Grupo Bimbo S.A. de C.V.:企業の戦略・SWOT・財務情報
    Grupo Bimbo S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Bimbo S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Royale Energy Inc (ROYL):石油・ガス:M&Aディール及び事業提携情報
    Summary Royale Energy Inc (Royale Energy) is an independent exploration and production company. The company undertakes the business of acquisition, development, and marketing of oil and natural gas properties. Its business activities comprise acquisition of oil and gas interests and proved reserves, …
  • Cenovus Energy Inc (CVE)-石油・ガス分野:企業M&A・提携分析
    Summary Cenovus Energy Inc (Cenovus Energy) is an oil and gas company, which explores, develops and produces crude oil and natural gas. The company also carries out processing of natural gas liquids. Cenovus Energy produces natural gas and oil through conventional and oil sands reserves. Its project …
  • Qube Holdings Ltd:戦略・SWOT・企業財務分析
    Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Funtastic Ltd (FUN):企業の財務・戦略的SWOT分析
    Funtastic Ltd (FUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Warner Music Group Corp.:企業の戦略的SWOT分析
    Warner Music Group Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Frontline Ltd (FRO):石油・ガス:M&Aディール及び事業提携情報
    Summary Frontline Ltd (Frontline) is a shipping company. It transports crude oil and its related refined petroleum products. The company owns and operates very large crude carriers (VLCCs), Suezmax tankers, and Aframax/LR2 tankers. Its vessels operate in the spot and time charter markets. Frontline’ …
  • Royal Dutch Shell Plc (RDSA)-エネルギー分野:企業M&A・提携分析
    Summary Royal Dutch Shell plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …
  • China Gezhouba Group Company Limited (600068):企業の財務・戦略的SWOT分析
    China Gezhouba Group Company Limited (600068) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Netflix Inc.:企業の戦略・SWOT・財務分析
    Netflix Inc. - Strategy, SWOT and Corporate Finance Report Summary Netflix Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pernod Ricard SA:戦略・SWOT・企業財務分析
    Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report Summary Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆